Amino acid-based enantiomerically pure 3-substituted 1,4-benzodiazepin-2-ones: a new class of anti-ischemic agents. 2007

Jitendra Kumar Mishra, and Puja Garg, and Preeti Dohare, and Ashutosh Kumar, and Mohammad Imran Siddiqi, and Madhur Ray, and Gautam Panda
Medicinal and Process Chemistry Division, Central Drug Research Institute, Lucknow 226001, UP, India.

A series of 3-substituted 1,4-benzodiazepin-2-ones derived from S and R amino acids were evaluated for their anti-ischemic activity in vitro. Treatment with compounds 7h, 16, 9d, and 17 decreased the apoptotic neuronal number, however increased the neuronal viability. The compounds decreasing apoptosis could protect neurons from the ischemic injury. The difference in the activities of 1,4-benzodiazepin-2-ones derived from S- and R-amino acids is discussed and explained on the basis of molecular modeling studies.

UI MeSH Term Description Entries
D007511 Ischemia A hypoperfusion of the BLOOD through an organ or tissue caused by a PATHOLOGIC CONSTRICTION or obstruction of its BLOOD VESSELS, or an absence of BLOOD CIRCULATION. Ischemias
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D009474 Neurons The basic cellular units of nervous tissue. Each neuron consists of a body, an axon, and dendrites. Their purpose is to receive, conduct, and transmit impulses in the NERVOUS SYSTEM. Nerve Cells,Cell, Nerve,Cells, Nerve,Nerve Cell,Neuron
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D005434 Flow Cytometry Technique using an instrument system for making, processing, and displaying one or more measurements on individual cells obtained from a cell suspension. Cells are usually stained with one or more fluorescent dyes specific to cell components of interest, e.g., DNA, and fluorescence of each cell is measured as it rapidly transverses the excitation beam (laser or mercury arc lamp). Fluorescence provides a quantitative measure of various biochemical and biophysical properties of the cell, as well as a basis for cell sorting. Other measurable optical parameters include light absorption and light scattering, the latter being applicable to the measurement of cell size, shape, density, granularity, and stain uptake. Cytofluorometry, Flow,Cytometry, Flow,Flow Microfluorimetry,Fluorescence-Activated Cell Sorting,Microfluorometry, Flow,Cell Sorting, Fluorescence-Activated,Cell Sortings, Fluorescence-Activated,Cytofluorometries, Flow,Cytometries, Flow,Flow Cytofluorometries,Flow Cytofluorometry,Flow Cytometries,Flow Microfluorometries,Flow Microfluorometry,Fluorescence Activated Cell Sorting,Fluorescence-Activated Cell Sortings,Microfluorimetry, Flow,Microfluorometries, Flow,Sorting, Fluorescence-Activated Cell,Sortings, Fluorescence-Activated Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000596 Amino Acids Organic compounds that generally contain an amino (-NH2) and a carboxyl (-COOH) group. Twenty alpha-amino acids are the subunits which are polymerized to form proteins. Amino Acid,Acid, Amino,Acids, Amino
D001570 Benzodiazepinones
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining

Related Publications

Jitendra Kumar Mishra, and Puja Garg, and Preeti Dohare, and Ashutosh Kumar, and Mohammad Imran Siddiqi, and Madhur Ray, and Gautam Panda
January 2010, Bioorganic & medicinal chemistry letters,
Jitendra Kumar Mishra, and Puja Garg, and Preeti Dohare, and Ashutosh Kumar, and Mohammad Imran Siddiqi, and Madhur Ray, and Gautam Panda
May 1968, Journal of medicinal chemistry,
Jitendra Kumar Mishra, and Puja Garg, and Preeti Dohare, and Ashutosh Kumar, and Mohammad Imran Siddiqi, and Madhur Ray, and Gautam Panda
December 1974, Bollettino chimico farmaceutico,
Jitendra Kumar Mishra, and Puja Garg, and Preeti Dohare, and Ashutosh Kumar, and Mohammad Imran Siddiqi, and Madhur Ray, and Gautam Panda
January 2017, Ukrainian biochemical journal,
Jitendra Kumar Mishra, and Puja Garg, and Preeti Dohare, and Ashutosh Kumar, and Mohammad Imran Siddiqi, and Madhur Ray, and Gautam Panda
April 2003, The Journal of organic chemistry,
Jitendra Kumar Mishra, and Puja Garg, and Preeti Dohare, and Ashutosh Kumar, and Mohammad Imran Siddiqi, and Madhur Ray, and Gautam Panda
May 2012, Chirality,
Jitendra Kumar Mishra, and Puja Garg, and Preeti Dohare, and Ashutosh Kumar, and Mohammad Imran Siddiqi, and Madhur Ray, and Gautam Panda
October 1973, Archiv der Pharmazie,
Jitendra Kumar Mishra, and Puja Garg, and Preeti Dohare, and Ashutosh Kumar, and Mohammad Imran Siddiqi, and Madhur Ray, and Gautam Panda
September 1979, Journal of medicinal chemistry,
Jitendra Kumar Mishra, and Puja Garg, and Preeti Dohare, and Ashutosh Kumar, and Mohammad Imran Siddiqi, and Madhur Ray, and Gautam Panda
November 2006, Journal of the American Chemical Society,
Jitendra Kumar Mishra, and Puja Garg, and Preeti Dohare, and Ashutosh Kumar, and Mohammad Imran Siddiqi, and Madhur Ray, and Gautam Panda
September 2010, Future medicinal chemistry,
Copied contents to your clipboard!